Evidence map›Paper›PMID 34522194›Full record

ArticleResearch in pharmaceutical sciences2021

Anti-inflammatory effect of

Napapan Kangwan, Komsak Pintha, Chakkrit Khanaree, Sarawut Kongkarnka, Teera Chewonarin, Maitree Suttajit

Open access · goldAbstract read
In one paragraph

Article in Research in pharmaceutical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Protective effects ofBiomedical reports · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Emulgels ContainingPolymers · 2022
    Article
  16. Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases.International journal of molecular sciences · 2021
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Napapan KangwanDivision of Physiology, School of Medical Sciences, University of Phayao, Phayao, Thailand.
Komsak PinthaDivision of Biochemistry, School of Medical Sciences, University of Phayao, Phayao, Thailand.
Chakkrit KhanareeSchool of Traditional and Alternative Medicine, Chiang Rai Rajabhat University, Chiang Rai, Thailand.
Sarawut KongkarnkaDepartment of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Teera ChewonarinDepartment of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Maitree SuttajitDivision of Biochemistry, School of Medical Sciences, University of Phayao, Phayao, Thailand.
University of Phayao · THChiang Mai University · THChiang Rai Rajabhat University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeUlcerative colitis is a chronic inflammatory bowel disease that involves diffused inflammation of the large intestine. Omega-3 fatty acid (FA) has been known to regulate the inflammatory response associated with ulcerative colitis pathogenesis. EXPERIMENTAL APPROACH: PSO was extracted using a cold-pressed extractor and FA composition of PSO was analyzed by GC-MS. Acute colitis in mice was induced with 3% DSS in drinking water for 7 days. Some mice were treated with PSO (20, 100, 200 mg/kg BW) for 3 weeks before the DSS administration. Sulfasalazine was used as a positive control. The clinical features, histopathologic, serum, and gene expression of proinflammatory cytokines in the colon were assessed. FINDING/

resultsPSO contained the highest proportion of ALA (61.51%). Furthermore, PSO pretreatment evidently reduced body weight loss, diminished diarrhea, gross bleeding, and DSS-induced colon shortening. PSO pretreatment attenuated histopathological changes in response to DSS-induced colitis. PSO pretreatment also markedly decreased inflammatory response in serum and the colon tissue of DSS-induced mice. CONCLUSION AND IMPLICATION: ALA in PSO is suggested to be mainly responsible for the reduction of DSS-induced colitis through suppressing inflammatory markers. PSO could be further developed as a functional health supplement, which would be beneficial for anti-inflammation in the colonic mucosa.

Indexed as

Anti-inflammationInflammatory bowel diseaseInflammatory cytokinesOmega-3 fatty acidPerilla seed oil

Identifiers

PMID34522194
PMCPMC8407152
OpenAlexW3196144853

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.